CATHERINE ROLLYSON: Open Payments
NPI 1841719259 · PEKIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 28 payments from 16 companies in 2025. Trend: 2023 $235 · 2024 $448 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $105 |
| Novo Nordisk Inc | 2 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $49 |
| Amgen Inc. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| SCPHARMACEUTICALS INC. | 1 | $31 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Astellas Pharma US Inc | 1 | $28 |
Products named: LEQVIO, Ozempic, UBRELVY, REXULTI, Cologuard Collection Kit, GEMTESA, FUROSCIX, QULIPTA.
Industry payments across IL — which companies pay providers there.
